SCHEMBL18735189

SCHEMBL18735189

CCC(C)C(=O)NC(C(=O)N(CC)CC)C(C)(C)SC(=O)CC(=O)OC

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18735145 0.91 MGAM (0.32) —
SCHEMBL18735161 0.91 — —
SCHEMBL18735144 0.90 — —
SCHEMBL18734928 0.88 — —
SCHEMBL18734944 0.84 — —
SCHEMBL18734938 0.84 METAP2 (0.30) —
SCHEMBL18735153 0.84 — —
SCHEMBL18735069 0.82 METAP2 (0.33) HSD17B10
SCHEMBL18735160 0.81 LMNA (0.31) —
SCHEMBL18735190 0.81 MGAM (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback